We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Citizens Financial Group
CFG
$30.4B
| $87.6M | 0.2% |
2,224,037
-926,129
| -29% | -$36.2M |
|
102
Coupang
CPNG
$27.8B
| $87.5M | 0.2% |
5,945,647
+5,805,220
| +4,134% | +$102M |
|
103
Advanced Micro Devices
AMD
$851B
| $87.3M | 0.2% |
1,348,532
+1,191,338
| +758% | +$78.6M |
|
|
K
104
DELISTED
Kellanova
K
| $87.2M | 0.2% |
1,303,347
+742,612
| +132% | +$50.4M |
|
105
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $85.1M | 0.19% |
854,400
-593,300
| -41% | -$59.8M |
|
|
SF
106
Stifel
SF
$12.3B
| $85M | 0.19% |
2,183,778
-252,665
| -10% | -$10M |
|
107
Alphabet (Google) Class C
GOOG
$3.9T
| $84.8M | 0.19% |
955,160
-494,817
| -34% | -$47.2M |
|
108
Carlisle Companies
CSL
$13.6B
| $84.5M | 0.19% |
358,466
+355,225
| +10,960% | +$91.4M |
|
109
Ares Capital
ARCC
$13.5B
| $83.8M | 0.19% |
4,535,836
+2,883,828
| +175% | +$54.2M |
|
110
3M
MMM
$89B
| $83.2M | 0.19% |
829,494
+763,287
| +1,153% | +$77.8M |
|
111
Conagra Brands
CAG
$7.07B
| $82.6M | 0.19% |
2,135,469
+1,663,932
| +353% | +$60.3M |
|
112
Ulta Beauty
ULTA
$20.4B
| $82.6M | 0.19% |
175,994
-55,992
| -24% | -$24.1M |
|
|
AKRO
113
DELISTED
Akero Therapeutics
AKRO
| $82.4M | 0.19% |
1,503,364
+752,524
| +100% | +$32.2M |
|
114
Deckers Outdoor
DECK
$13.3B
| $81.2M | 0.18% |
1,220,598
+961,014
| +370% | +$58.1M |
|
115
CALL
SPDR Gold Trust
GLD
$131B
| $81M | 0.18% |
477,500
-206,900
| -30% | -$33.3M |
|
116
Aptiv
APTV
$12B
| $80.8M | 0.18% |
868,082
+640,038
| +281% | +$60.8M |
|
117
On Holding
ONON
$11.9B
| $80.7M | 0.18% |
4,704,690
+828,014
| +21% | +$14.5M |
|
118
Roku
ROKU
$21.1B
| $79.9M | 0.18% |
1,963,896
+1,674,747
| +579% | +$87.5M |
|
119
Becton Dickinson
BDX
$43.1B
| $79.8M | 0.18% |
+313,739
| New | +$74.1M |
|
|
120
Johnson & Johnson
JNJ
$635B
| $79.4M | 0.18% |
449,413
-1,804,959
| -80% | -$312M |
|
121
Veeva Systems
VEEV
$30.3B
| $77.9M | 0.18% |
482,673
+478,071
| +10,388% | +$81.7M |
|
122
Ferrari
RACE
$63.3B
| $77.4M | 0.17% |
362,461
+141,566
| +64% | +$29.2M |
|
|
WBA
123
DELISTED
Walgreens Boots Alliance
WBA
| $77.4M | 0.17% |
2,072,024
+852,725
| +70% | +$32.1M |
|
124
Boston Properties
BXP
$11B
| $76.5M | 0.17% |
1,131,303
+691,464
| +157% | +$49M |
|
125
TransUnion
TRU
$14.8B
| $76.3M | 0.17% |
1,344,844
-837,302
| -38% | -$49.1M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.